1537032-82-8
1537032-82-8
Chemical Structure
Avelumab
Synonym(s): Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C
- CAS No.: 1537032-82-8
- Formula:N/A
- Molecular Weight:(150 kDa)
SMILES: [Avelumab]
Biological Activity: Avelumab (Anti-Human PD-L1) a fully human IgG1 anti-PD-L1 monoclonal antibody (mAb) with potential antibody-dependent cell-mediated cytotoxicity (ADCC). Avelumab enhances ADCC on several cancer cell lines expressing PD-L1. Avelumab can be used for the study of chordoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Avelumab | 95% | Avelumab (Anti-Human PD-L1) a fully human IgG1 anti-PD-L1 monoclonal antibody (mAb) with potential antibody-dependent cell-mediated cytotoxicity (ADCC). Avelumab enhances ADCC on several cancer cell lines expressing PD-L1. Avelumab can be used for the study of chordoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Avelumab (anti-PD-L1) | 97.44% | Avelumab (anti-PD-L1) a fully human IgG1 anti-PD-L1 monoclonal antibody (mAb) with potential antibody-dependent cell-mediated cytotoxicity (ADCC). Avelumab (anti-PD-L1) enhances ADCC on several cancer cell lines expressing PD-L1. Avelumab (anti-PD-L1) can be used for the study of chordoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
